Acute toxic epidermal necrolysis reaction post single dose pembrolizumab with preceding cephalosporin exposure: successful rechallenge with anti‐PD‐1 therapy

Saved in:
Bibliographic Details
Published inInternal medicine journal Vol. 49; no. 8; pp. 1051 - 1053
Main Authors Lomax, Anna J., McQuillan, Peter I. A., Hall, Anthony, McArthur, Grant A.
Format Journal Article
LanguageEnglish
Published Melbourne John Wiley & Sons Australia, Ltd 01.08.2019
Wiley Subscription Services, Inc
Subjects
Aged
Antibodies, Monoclonal, Humanized - therapeutic use
Antibodies, Monoclonal, Humanized - toxicity
Cephalosporins - therapeutic use
Female
Humans
Melanoma - drug therapy
Monoclonal antibodies
Pembrolizumab
Skin - pathology
Stevens-Johnson Syndrome - etiology
Stevens-Johnson Syndrome - pathology
Toxic epidermal necrolysis
Online AccessGet full text

Cover

More Information
ISSN:1444-0903
1445-5994
DOI:10.1111/imj.14388